June 30, 2022

“Latest News About Biosimilars” – A Biosimilars Forum sponsored episode

We’ve heard biosimilars have been coming for a while. Now hear the latest news from Julie Reed, Executive Director with the Biosimilars Forum who answers questions about what biosimilars can be used for psoriasis, the meaning of terms such as reference product and interchangeable, and just how much biosimilars will lower health care costs for those with psoriasis through greater access to biosimilars. Julie also discusses the need for policies that remove barriers and incentivize the use of biosimilars through add-on payments, removing out-of-pocket Medicare costs, and a shared savings model.

Related Items

Stay in the Know

Expert tips, can’t-miss events, and the latest news, straight to your inbox.

National Health Council Standards of ExcellenceCharity NavigatorCommunity Health Charities logo

Copyright © 1996-2023 National Psoriasis Foundation/USA

Duplication, rebroadcast, republication, or other use of content appearing on this website is prohibited without written permission of the National Psoriasis Foundation (NPF).

NPF does not endorse or accept any responsibility for the content of external websites.

NPF does not endorse any specific treatments or medications for psoriasis and psoriatic arthritis.

We use cookies to offer you a better experience and analyze our site traffic. By continuing to use this website, you consent to the use of cookies in accordance with our Privacy Policy.